GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ToolGen Inc (XKRX:199800) » Definitions » EV-to-EBIT

ToolGen (XKRX:199800) EV-to-EBIT : 24.15 (As of Jun. 02, 2025)


View and export this data going back to 2014. Start your Free Trial

What is ToolGen EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ToolGen's Enterprise Value is ₩217,069.5 Mil. ToolGen's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₩8,988.8 Mil. Therefore, ToolGen's EV-to-EBIT for today is 24.15.

The historical rank and industry rank for ToolGen's EV-to-EBIT or its related term are showing as below:

XKRX:199800' s EV-to-EBIT Range Over the Past 10 Years
Min: -208.63   Med: -20.19   Max: 36.24
Current: 24.15

During the past 11 years, the highest EV-to-EBIT of ToolGen was 36.24. The lowest was -208.63. And the median was -20.19.

XKRX:199800's EV-to-EBIT is ranked worse than
72.77% of 470 companies
in the Biotechnology industry
Industry Median: 8.875 vs XKRX:199800: 24.15

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. ToolGen's Enterprise Value for the quarter that ended in Mar. 2025 was ₩219,045.3 Mil. ToolGen's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₩8,988.8 Mil. ToolGen's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 4.10%.


ToolGen EV-to-EBIT Historical Data

The historical data trend for ToolGen's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ToolGen EV-to-EBIT Chart

ToolGen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -48.90 -30.93 -20.94 -13.16 30.51

ToolGen Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.67 -12.11 -10.34 30.51 24.37

Competitive Comparison of ToolGen's EV-to-EBIT

For the Biotechnology subindustry, ToolGen's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ToolGen's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ToolGen's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ToolGen's EV-to-EBIT falls into.


;
;

ToolGen EV-to-EBIT Calculation

ToolGen's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=217069.538/8988.802
=24.15

ToolGen's current Enterprise Value is ₩217,069.5 Mil.
ToolGen's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,988.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ToolGen  (XKRX:199800) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

ToolGen's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=8988.802/219045.289
=4.10 %

ToolGen's Enterprise Value for the quarter that ended in Mar. 2025 was ₩219,045.3 Mil.
ToolGen's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,988.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ToolGen EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of ToolGen's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


ToolGen Business Description

Traded in Other Exchanges
N/A
Address
KOR-collar Gasan Digital Valley 1 to 219 digital Byeoksan, 6th 1204 No. ENG No. 1204, Byucksan Digital Valley 6-cha, 219 Gasan Digital 1-ro, Geumcheon-gu, Seoul, KOR
ToolGen Inc is a biotechnology company, which focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified, gRNA/Cas9, and recombinant Cas9 protein, which offers ready-to-use reagents for genome engineering experiments. The company also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services.

ToolGen Headlines

No Headlines